Will Ocugen Hit New Highs In January?

If you are looking for stocks that might have made gains in premarket trade today, the Ocugen Inc (NASDAQ: OCGN) stocks might be an interesting one to track.

Will Ocugen Hit New Highs In January?

The stock has gained as much as 5% this morning as investors piled on to it today. However, more importantly, the Ocugen stock has managed to maintain the momentum it gained last week when it made significant gains.

The company saw its stock soar last week after it emerged that its partner Bharat Biotech had been awarded the coveted emergency use authorization for its COVID 19 vaccine by the regulators in India.

Ocugen has partnered with Bharat Biotech to bring the vaccine to the United States and hence the development is a major boost. That being said, it should be noted that some experts have expressed doubts about the Bharat Biotech COVID 19 vaccine since no efficacy test results had been furnished. However, that has not stopped the momentum in the Ocugen stock.

Will Ocugen Hit New Highs In January?

Anthony Gonzales

Biotech, Tech, and Crypto reporterAnthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.